The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $69.15

Today's change+0.89 +1.30%
Updated May 25 4:00 PM EDT. Delayed by at least 15 minutes.
 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $69.15

Today's change+0.89 +1.30%
Updated May 25 4:00 PM EDT. Delayed by at least 15 minutes.

DexCom Inc up (U.S.)$0.89

DexCom Inc closed up Thursday by (U.S.)$0.89 or 1.30% to (U.S.)$69.15. Over the last five days, shares have gained 0.71% and 15.83% year to date. Shares have underperformed the S&P 500 by 9.66% during the last year.

Key company metrics

  • Open(U.S.) $68.50
  • Previous close(U.S.) $68.26
  • High(U.S.) $69.35
  • Low(U.S.) $67.90
  • Bid / Ask(U.S.) $0.00 / (U.S.) $82.00
  • YTD % change+15.83%
  • Volume1,040,545
  • Average volume (10-day)1,055,782
  • Average volume (1-month)1,179,789
  • Average volume (3-month)1,028,430
  • 52-week range(U.S.) $57.68 to (U.S.) $96.38
  • Beta0.64
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.04
Updated May 25 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.06%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue142171149137
Total other revenue--------
Total revenue142171149137
Gross profit9411710186
Total cost of revenue48554852
Total operating expense183177167157
Selling / general / administrative86797669
Research & development48444436
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-40-6-19-20
Interest income (expense), net non-operating-1000
Gain (loss) on sale of assets--------
Other--------
Income before tax-40-7-19-20
Income after tax-42-7-19-20
Income tax, total1000
Net income-42-7-19-20
Total adjustments to net income--------
Net income before extra. items-42-7-19-20
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-42-7-19-20
Inc. avail. to common incl. extra. items-42-7-19-20
Diluted net income-42-7-19-20
Dilution adjustment0------
Diluted weighted average shares85858484
Diluted EPS excluding extraordinary itemsvalue per share-0.49-0.09-0.22-0.24
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.49-0.09-0.22-0.24